Shaun Ng will leave his position as managing director of risk, analytics and operations at Cleveland Clinic’s Investment Office in mid-December, according to a Dec. 4 news release shared with Becker’s.
Category: ROOT
Florida hospital names CEO
Robert Dahl has been named CEO of Broward Health Imperial Point in Fort Lauderdale, Fla., effective Dec. 2.
MaineHealth names new C-suite leader
Erin Brown has been named vice president of advancement and chief development officer of Portland-based MaineHealth.
Hospital workplace violence is a public health emergency. Why is no one listening?
As many of us scroll through our favorite news app, we are greeted by reports of workplace violence, from verbal and physical confrontations to fatal shootings. What is often missing from the headlines are stories of the increasingly high frequency of …
Unlocking the power of physician incentives
Physician incentives have long served as a way to improve patient outcomes and manage costs. But, a Dec. 3 article by the Association for Physician Leadership reportedly found several things that systems can do to improve the design of their incentive …
Tower Health names next CEO
West Reading, Pa.-based Tower Health is preparing for a leadership transition.
'Nurse anesthesiologist' title argument arises in Washington
The District of Columbia’s health department is considering allowing certified registered nurse anesthetists to use the title “nurse anesthesiologist.” Organizations representing healthcare professionals have argued for and against the title change.&nb…
What's new with CVS Health
From layoffs to leadership appointments, here are nine updates from CVS Health in the last 60 days:
UnitedHealthcare CEO shot and killed: 7 notes
UnitedHealthcare’s CEO, Brian Thompson, was fatally shot on the morning of Dec. 4 while exiting a hotel in New York City, according to the New York Police Department.
The race to create an oral GLP-1 obesity drug: 4 things to know
The push to develop the first oral GLP-1 receptor drug for obesity is heating up, as three phase 3 drugs race to become the first approved oral treatment for obesity, Global Data reported Dec. 2.
